The Oncosearch | Oncotarget

BCAS1 defines a heterogeneous cell population in diffuse gliomas Research Paper

Raquel Morales-Gallel, María José Ulloa-Navas, Patricia García-Tárraga, Ricardo Prat-Acín, Gaspar Reynés, Pedro Pérez-Borredá, Luis Rubio, Vivian Capilla-González, Jaime Ferrer-Lozano, José Manuel García-Verdugo

Published Jan 10, 2024 · Vol. 15, No. 1 · pp. 49-64

Keywords: brain tumor, diffuse glioma, oligodendroglioma, glioblastoma, BCAS1

The fate of drug discovery in academia; dumping in the publication landfill? Editorial

Uzma Saqib, Isaac S. Demaree, Alexander G. Obukhov, Mirza S. Baig, Amiram Ariel, Krishnan Hajela

Published Jan 6, 2024 · Vol. 15, No. 1 · pp. 31-34

Keywords: drug discovery and development, clinical trials, academia-industry collaboration, translational research, drug database

ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines Research Paper

Mathew Lozinski, Nikola A. Bowden, Moira C. Graves, Michael Fay, Bryan W. Day, Brett W. Stringer, Paul A. Tooney

Published Jan 5, 2024 · Vol. 15, No. 1 · pp. 1-18

Keywords: glioblastoma, DNA damage response, ataxia-telangiectasia and rad3-related protein, radiation therapy, temozolomide

Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report Research Paper

Shreya Bhatia, Manuel G. Cortez, Spencer Lessans, Wade T. Iams

Published Jan 5, 2024 · Vol. 15, No. 1 · pp. 27-30

Keywords: EGFR mutation, leptomeningeal disease, non-small cell lung cancer, osimertinib

Combining causal and correlative approaches to discover biomarkers of response to paclitaxel Research Perspective

Alberto Moscona-Nissan, Karl J. Habashy, Victor A. Arrieta, Adam M. Sonabend, Crismita Dmello

Published Jan 2, 2024 · Vol. 15, No. 1 · pp. 117-122

Keywords: glioblastoma, predictive biomarker, CRISPR screen, paclitaxel

Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma Research Perspective

Bilal M. El-Masri, Benedeta Leka, Fatima Mustapha, Michael Tveden Gundesen, Maja Hinge, Thomas Lund, Thomas L. Andersen, Marta Diaz-delCastillo, Abbas Jafari

Published Jan 2, 2024 · Vol. 15, No. 1 · pp. 20-26

Keywords: multiple myeloma, MGUS, bone marrow adipocyte

Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma Research Perspective

Ashley Del Dosso, Elizabeth Tadevosyan, James R. Berenson

Published Dec 23, 2023 · Vol. 15, No. 1 · pp. 65-75

Keywords: multiple myeloma, ruxolitinib, JAK/STAT, cytokine, clinical trial

Transformation-associated recombination (TAR) cloning and its applications for gene function; genome architecture and evolution; biotechnology and biomedicine Review

Natalay Kouprina, Vladimir Larionov

Published Dec 19, 2023 · Vol. 14, No. 1 · pp. 1009-1033

Keywords: transformation-associated recombination, TAR, microbes, biomedicine, biotechnology

Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation Research Perspective

Mark Lee, Luc GT Morris

Published Dec 15, 2023 · Vol. 15, No. 1 · pp. 36-48

Keywords: thyroid cancer, drug resistance, anaplastic transformation, BRAF inhibitors, PIK3CA

The pharmacodynamic and mechanistic foundation for the antineoplastic effects of GFH009, a potent and highly selective CDK9 inhibitor for the treatment of hematologic malignancies Research Paper

Fusheng Zhou, Lili Tang, Siyuan Le, Mei Ge, Dragan Cicic, Fubo Xie, Jinmin Ren, Jiong Lan, Qiang Lu

Published Dec 9, 2023 · Vol. 14, No. 1 · pp. 997-1008

Keywords: GFH009, CDK9, cancer, leukemia, cell cycle

Therapeutically harnessing cancer stem cell-derived exosomes Editorial

Yong Teng

Published Dec 7, 2023 · Vol. 14, No. 1 · pp. 995-996

Keywords: cancer stem cells; exosomes, the tumor microenvironment, therapeutic target, anticancer strategy

Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in Brazil: Balancing efficacy, safety, and tolerability Review

Flávia Dias Xavier, Danielle Leão Cordeiro de Farias, Abrahão Elias Hallack Neto, Glaciano Nogueira Ribeiro, Marco Aurelio Salvino de Araujo, Thiago Xavier Carneiro, Otavio Cesar Carvalho Guimarães Baiocchi

Published Dec 5, 2023 · Vol. 14, No. 1 · pp. 977-994

Keywords: brentuximab vedotin, drug therapy, hodgkin lymphoma, nivolumab, pembrolizumab

Osteopontin induces mitochondrial biogenesis in deadherent cancer cells Research Paper

Gulimirerouzi Fnu, Georg F. Weber

Published Nov 24, 2023 · Vol. 14, No. 1 · pp. 957-969

Keywords: metastasis, metabolism, anchorage independence, mitochondrial mass, peroxide

Risk factors for long-term arm morbidities following breast cancer treatments: A systematic review Review

Ifat Klein, Michael Friger, Merav Ben David, Danit Shahar

Published Nov 24, 2023 · Vol. 14, No. 1 · pp. 921-942

Keywords: risk factors, arm morbidity, physical rehabilitation, breast cancer

Plasma levels of BCMA-positive extracellular vesicles correlate to response and side effects in myeloma patients treated with belantamab-mafodotin Research Paper

Carsten Springer, Jürgen Krauter, Arne Trummer

Published Nov 23, 2023 · Vol. 14, No. 1 · pp. 949-956

Keywords: myeloma, b cell maturation antigen, extracellular vesicles, belantamab-mafodotin, eryptosis

Melatonin and carcinogenesis in mice: the 50th anniversary of relationships Research Perspective

Vladimir N. Anisimov, Alexey G. Golubev

Published Nov 22, 2023 · Vol. 14, No. 1 · pp. 972-976

Keywords: cancer, melatonin, mice

Correction: Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells Correction

Yunfei Liao, Lulu Chen, Yong Feng, Jacson Shen, Yan Gao, Gregory Cote, Edwin Choy, David Harmon, Henry Mankin, Francis Hornicek, Zhenfeng Duan

Published Nov 21, 2023 · Vol. 15, No. 1 · pp. 104-105

FAAH inhibition ameliorates breast cancer in a murine model Research Paper

Mallika Tripathy, Amy Bui, Jared Henderson, Jeffrey Sun, Christian Rutan Woods, Soumya Somani, Thao Doan, Anto Sam Crosslee Louis Sam Titus, Chandra Mohan

Published Oct 26, 2023 · Vol. 14, No. 1 · pp. 910-918

Keywords: FAAH, breast cancer, cancer therapy, apoptosis

Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase Correction

Recep Bayraktar, Martin Pichler, Pinar Kanlikilicer, Cristina Ivan, Emine Bayraktar, Nermin Kahraman, Burcu Aslan, Serpil Oguztuzun, Mustafa Ulasli, Ahmet Arslan, George Calin, Gabriel Lopez-Berestein, Bulent Ozpolat

Published Oct 26, 2023 · Vol. 14, No. 1 · pp. 908-909

Retraction: Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice Retraction

Fariba Poosti, Ruchi Bansal, Saleh Yazdani, Jai Prakash, Leonie Beljaars, Jacob van den Born, Martin H. de Borst, Harry van Goor, Jan-Luuk Hillebrands, Klaas Poelstra

Published Oct 25, 2023 · Vol. 15, No. 1 · pp. 35-35

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

BCAS1 defines a heterogeneous cell population in diffuse gliomas Research Paper

The fate of drug discovery in academia; dumping in the publication landfill? Editorial

ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines Research Paper

Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report Research Paper

Combining causal and correlative approaches to discover biomarkers of response to paclitaxel Research Perspective

Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma Research Perspective

Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma Research Perspective

Transformation-associated recombination (TAR) cloning and its applications for gene function; genome architecture and evolution; biotechnology and biomedicine Review

Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation Research Perspective

The pharmacodynamic and mechanistic foundation for the antineoplastic effects of GFH009, a potent and highly selective CDK9 inhibitor for the treatment of hematologic malignancies Research Paper

Therapeutically harnessing cancer stem cell-derived exosomes Editorial

Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in Brazil: Balancing efficacy, safety, and tolerability Review

Osteopontin induces mitochondrial biogenesis in deadherent cancer cells Research Paper

Risk factors for long-term arm morbidities following breast cancer treatments: A systematic review Review

Plasma levels of BCMA-positive extracellular vesicles correlate to response and side effects in myeloma patients treated with belantamab-mafodotin Research Paper

Melatonin and carcinogenesis in mice: the 50th anniversary of relationships Research Perspective

Correction: Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells Correction

FAAH inhibition ameliorates breast cancer in a murine model Research Paper

Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase Correction

Retraction: Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice Retraction

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

BCAS1 defines a heterogeneous cell population in diffuse gliomas Research Paper

The fate of drug discovery in academia; dumping in the publication landfill? Editorial

ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines Research Paper

Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report Research Paper

Combining causal and correlative approaches to discover biomarkers of response to paclitaxel Research Perspective

Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma Research Perspective

Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma Research Perspective

Transformation-associated recombination (TAR) cloning and its applications for gene function; genome architecture and evolution; biotechnology and biomedicine Review

Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation Research Perspective

The pharmacodynamic and mechanistic foundation for the antineoplastic effects of GFH009, a potent and highly selective CDK9 inhibitor for the treatment of hematologic malignancies Research Paper

Therapeutically harnessing cancer stem cell-derived exosomes Editorial

Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in Brazil: Balancing efficacy, safety, and tolerability Review

Osteopontin induces mitochondrial biogenesis in deadherent cancer cells Research Paper

Risk factors for long-term arm morbidities following breast cancer treatments: A systematic review Review

Plasma levels of BCMA-positive extracellular vesicles correlate to response and side effects in myeloma patients treated with belantamab-mafodotin Research Paper

Melatonin and carcinogenesis in mice: the 50th anniversary of relationships Research Perspective

Correction: Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells Correction

FAAH inhibition ameliorates breast cancer in a murine model Research Paper

Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase Correction

Retraction: Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice Retraction